000			02184 a2200673 4500
005			20250515182711.0
264		0	_c20100603
008			201006s 0 0 eng d
022			_a1476-5365
024	7		_a10.1038/bmt.2009.189 _2doi
040			_aNLM _beng _cNLM
100	1		_aCiurea, S O
245	0	0	_aReduced-intensity conditioning using fludarabine, melphalan and thiotepa for adult patients undergoing haploidentical SCT. _h[electronic resource]
260			_bBone marrow transplantation _cMar 2010
300			_a429-36 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase II; Journal Article
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAntilymphocyte Serum _xadministration & dosage
650	0	4	_aChild
650	0	4	_aFemale
650	0	4	_aHematologic Neoplasms _xtherapy
650	0	4	_aHematopoietic Stem Cell Transplantation _xadverse effects
650	0	4	_aHumans
650	0	4	_aInfections _xetiology
650	0	4	_aLeukemia, Myeloid, Acute _xtherapy
650	0	4	_aMale
650	0	4	_aMelphalan _xadministration & dosage
650	0	4	_aMiddle Aged
650	0	4	_aMyeloablative Agonists _xadministration & dosage
650	0	4	_aMyelodysplastic Syndromes _xtherapy
650	0	4	_aSurvival Rate
650	0	4	_aT-Lymphocytes _ximmunology
650	0	4	_aThiotepa _xadministration & dosage
650	0	4	_aTransplantation Conditioning _xmethods
650	0	4	_aTransplantation, Homologous
650	0	4	_aTreatment Outcome
650	0	4	_aVidarabine _xadministration & dosage
650	0	4	_aYoung Adult
700	1		_aSaliba, R
700	1		_aRondon, G
700	1		_aPesoa, S
700	1		_aCano, P
700	1		_aFernandez-Vina, M
700	1		_aQureshi, S
700	1		_aWorth, L L
700	1		_aMcMannis, J
700	1		_aKebriaei, P
700	1		_aJones, R B
700	1		_aKorbling, M
700	1		_aQazilbash, M
700	1		_aShpall, E J
700	1		_aGiralt, S
700	1		_ade Lima, M
700	1		_aChamplin, R E
700	1		_aGajewski, J
773	0		_tBone marrow transplantation _gvol. 45 _gno. 3 _gp. 429-36
856	4	0	_uhttps://doi.org/10.1038/bmt.2009.189 _zAvailable from publisher's website
999			_c19074448 _d19074448